Skin care brand Cannuka only came to market towards the end of last year, and already the company has received $750,000 in funding and seen 70 percent month-to-month growth in sales.
What’s the secret ingredient behind its success? Cannabis.
The brand’s products consist of a combination of CBD oils and manuka honey.
“CBD...is a very powerful anti-inflammatory...But we knew we needed to complement that with another ingredient,” explained Cannuka's Founder and CEO, Michael Bumgarner. “That’s when we found manuka honey, [which] is the most powerful antibacterial honey in the world.”
On top of the ingredients, Cannuka’s branding was designed to appeal to a wider market.
“We knew because we’re in the cannabis space we had to be approachable,” said Bumgarner. “It’s harder to explain the benefits because you have that stigma still about it.”
So far, Cannuka has been selling direct-to-consumer through its website but now wants to hit brick-and-mortar stores.
For the full interview, [click here](https://cheddar.com/videos/inside-the-power-of-cbd-for-skincare).
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
A look into how disruption, AI, and global economic trends are transforming the modern supply chain with Jeremy Jansen, Head of Supply Chain at Wells Fargo.
